Anti-Angiogenesis Maintenance Therapy in Newly Diagnosed and Relapsed Ovarian Cancer: A Meta-analysis of Phase III Randomized Controlled Trials

Código QR

Anti-Angiogenesis Maintenance Therapy in Newly Diagnosed and Relapsed Ovarian Cancer: A Meta-analysis of Phase III Randomized Controlled Trials

Aim: Anti-angiogenesis agents have been added as maintenance therapy in ovarian cancer over the past decade. The aim of this meta-analysis was to analyze the efficacy of anti-angiogenesis therapy in newly diagnosed and relapsed ovarian cancer.Methods: PubMed, Embase, and Cochrane databases were sear...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yizi Wang, Shitai Zhang, Zixuan Song, Ling Ouyang, Yan Li
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	anti-angiogenesis meta-analysis newly diagnosed ovarian cancer relapsed ovarian cancer adverse events Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/71b18faf8fd545ba87a8b6d9b778486e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Maintenance Treatment of Newly Diagnosed Advanced Ovarian Cancer: Time for a Paradigm Shift?
por: Paul DiSilvestro, et al.
Publicado: (2021)

Clinicopathological Determinants of Recurrence Risk and Survival in Mucinous Ovarian Carcinoma
por: Robert L. Hollis, et al.
Publicado: (2021)

Depressive and Anxiety Symptoms Are Predictors of Seizure Recurrence in Adults With Newly Diagnosed Epilepsy
por: Rui Zhong, et al.
Publicado: (2021)

Knockdown of growth factor receptor bound protein 7 suppresses angiogenesis by inhibiting the secretion of vascular endothelial growth factor A in ovarian cancer cells
por: Qiong Xu, et al.
Publicado: (2021)

Newly-Diagnosed Diabetes and Sustained Hyperglycemia are Associated with Poorer Outcomes in COVID-19 Inpatients Without Pre-Existing Diabetes
por: Lin L, et al.
Publicado: (2021)

Risky Sexual Practice, Sexually Transmitted Infection and Associated Factors Among Newly Diagnosed HIV-positive People in Northwest Ethiopia
por: Moges NA, et al.
Publicado: (2020)

The role of newly diagnosed diabetes mellitus for poor in-hospital prognosis of coronary artery bypass grafting
por: Alexei N. Sumin, et al.
Publicado: (2018)

The Factors Influencing the Renal Glucose Threshold in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
por: Cui SS, et al.
Publicado: (2021)

The Gut Microbial Diversity of Newly Diagnosed Diabetics but Not of Prediabetics Is Significantly Different from That of Healthy Nondiabetics
por: Akshay H. Gaike, et al.
Publicado: (2020)

Time to Antiretroviral Therapy Initiation and Its Predictors Among Newly Diagnosed HIV-Positive People in Nekemte Town, Western Ethiopia: Claim of Universal Test and Treat
por: Bayisa L, et al.
Publicado: (2021)

VEGF Concentration in a Preovulatory Leading Follicle Relates to Ovarian Reserve and Oocyte Maturation during Ovarian Stimulation with GnRH Antagonist Protocol in In Vitro Fertilization Cycle
por: Wen-Bin Wu, et al.
Publicado: (2021)

Co-Delivery of Curcumin and Paclitaxel by “Core-Shell” Targeting Amphiphilic Copolymer to Reverse Resistance in the Treatment of Ovarian Cancer
por: Zhao MD, et al.
Publicado: (2019)

Screening of CXC chemokines in the microenvironment of ovarian cancer and the biological function of CXCL10
por: Weiyuan Li, et al.
Publicado: (2021)

Identification of 5-methylcytosine-related signature for predicting prognosis in ovarian cancer
por: Wang,Lei, et al.
Publicado: (2021)

Pain Control, Acceptance and Adjustment to the Disease among Patients with Ovarian, Endometrial and Breast Cancer in Poland
por: Aleksandra Czerw, et al.
Publicado: (2021)

A Rapidly Enlarging Ovarian Cyst in a Pregnant Patient: The Surprise
por: Stephanie Rodriguez, et al.
Publicado: (2021)

Dermatomyositis and/or polymyositis as a paraneoplastic manifestation of ovarian cancer: a systematic review
por: Victoria Psomiadou, et al.
Publicado: (2021)

Epigenetic Therapy Augments Classic Chemotherapy in Suppressing the Growth of 3D High-Grade Serous Ovarian Cancer Spheroids over an Extended Period of Time
por: Michelle Bilbao, et al.
Publicado: (2021)

The impact of STAT3 and phospho-STAT3 expression on the prognosis and clinicopathology of ovarian cancer: a systematic review and meta-analysis
por: Shuo Gao, et al.
Publicado: (2021)

Is radiation-induced ovarian ablation in breast cancer an obsolete procedure? Results of a meta-analysis
por: Al Asiri M, et al.
Publicado: (2016)

Comparison of the Efficacy and Safety of PARP Inhibitors as a Monotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: A Network Meta-Analysis
por: Hongmei Wang, et al.
Publicado: (2021)

Hormonal Characteristics of Women Receiving Ovarian Tissue Transplantation with or without Endogenous Ovarian Activity
por: Vinnie Hornshøj Greve, et al.
Publicado: (2021)

Association between decreased ovarian reserve and poor oocyte quality
por: Viviane Margareth Scantamburlo, et al.
Publicado: (2021)

RISK FACTORS AND CRITERIA FOR PREDICTION OF OVARIAN HYPERSTIMULATION SYNDROME
por: N. V. Protopopova, et al.
Publicado: (2012)

Quantitative Analysis of the Efficacy of PARP Inhibitors as Maintenance Therapy in Recurrent Ovarian Cancer
por: Lili Gao, et al.
Publicado: (2021)

Sitagliptin Increases Beta-Cell Function and Decreases Insulin Resistance in Newly Diagnosed Vietnamese Patients with Type 2 Diabetes Mellitus
por: Le TD, et al.
Publicado: (2020)

Selection and Characterization of Vimentin-Binding Aptamer Motifs for Ovarian Cancer
por: Andrea M. Costello, et al.
Publicado: (2021)

Clinical value of bioelectrical properties of cancerous tissue in advanced epithelial ovarian cancer patients
por: Paula Cunnea, et al.
Publicado: (2018)

Resveratrol Targets a Variety of Oncogenic and Oncosuppressive Signaling for Ovarian Cancer Prevention and Treatment
por: Xue-Ling Xu, et al.
Publicado: (2021)

The association between lymph node metastases and long-term survival in patients with epithelial ovarian cancer
por: Katarzyna Lepinay, et al.
Publicado: (2020)

Assessment of prognostic value of tissue inhibitors of metalloproteinase 3 (TIMP3) protein in ovarian cancer
por: Sahar Hakamy, et al.
Publicado: (2021)

MicroRNA-663 facilitates the growth, migration and invasion of ovarian cancer cell by inhibiting TUSC2
por: Xie,Hui Hui, et al.
Publicado: (2019)

Discovery of novel serum metabolic biomarkers in patients with polycystic ovarian syndrome and premature ovarian failure
por: Jiying Chen, et al.
Publicado: (2021)

Downregulation of TGF-β1 suppressed proliferation and increased chemosensitivity of ovarian cancer cells by promoting BRCA1/Smad3 signaling
por: Wang,Yanqiu, et al.
Publicado: (2018)

Plasma Exosomes of Patients with Breast and Ovarian Tumors Contain an Inactive 20S Proteasome
por: Natalia Yunusova, et al.
Publicado: (2021)

Modern Concepts of Clinical and Diagnostic Criteria for Premature Ovarian Failure (Literature Review)
por: M. D. Salimova, et al.
Publicado: (2021)

Breast Carcinomatous Lymphangitis as an Unusual Presentation of Ovarian Cancer
por: Barbara Muoio, et al.
Publicado: (2021)

Epiphycan Predicts Poor Outcomes and Promotes Metastasis in Ovarian Cancer
por: Lu Deng, et al.
Publicado: (2021)

The clinical and pathological characteristics and survival of patients with advanced ovarian cancer
por: Popović Miroslav, et al.
Publicado: (2021)

State of the problem of early diagnosis and treatment of benign ovarian tumors in postmenopausal patients (literature review)
por: Nataliia M. Podzolkova, et al.
Publicado: (2021)